This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...

Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

Abbott Laboratories (ABT) stock is down as the FDA classifies the company's recent recall of FreeStyle Libre 3 glucose ...

Publisher JOYCITY and developer WOORE will host a closed beta test for premium football game Freestyle Football 2 from January 30 to February 2, the companies announced. Sign-ups are available via the ...

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified Abbott's recall of certain glucose monitoring sensors as the most serious after reports tied the devices to seven deaths ...

CureMD Healthcare today announced the Rural Health Accelerator Package, a comprehensive health information technology platform designed to help rural healthcare providers and state health agencies ...

Every year there’s a fresh rumour that the next Apple Watch is finally going to track blood sugar levels without needles - and with every launch, that promise fades, leaving us with the same old ...

Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...